Director, Centre for Nanotechnology & Advanced Biomaterials.
Research Interests: Regenerative medicine, stem cells, drug delivery systems.
Dr. Swaminathan received his Ph.D. from the Department of Chemical Engineering at Drexel University, Philadelphia, USA and worked on the development low temperature setting polymer – ceramic composite cements for bone tissue engineering and the thesis was nominated for the Best Dissertation Award. After his Ph. D. he joined as a Research Associate in the Department of Orthopaedic Surgery at the University of Virginia, Charlottesville, USA where he studied the application of low temperature setting cements for spinal fusions. Dr. S. Swaminathan has filed four international patents and they have been commercialized by Novabone Products, USA, Q Glass, USA and Aldrich Chemicals, USA.
Dr. S. Swaminathan is currently the Director, Centre for Nanotechnology & Advanced Biomaterials (CeNTAB) at SASTRA University. CeNTAB is involved in multi-faceted areas to evolve cutting-edge technologies in health care. One of the major areas of research is in the development of novel nanostructured biomaterials for tissue engineering. Currently, research is focused on the development of novel three- dimensional polymeric nanofiber scaffolds for tissue engineering of skin, cardiovascular arteries, and nerve regeneration using aligned and random nanofibers.